vs

Side-by-side financial comparison of OPKO HEALTH, INC. (OPK) and 1ST SOURCE CORP (SRCE). Click either name above to swap in a different company.

OPKO HEALTH, INC. is the larger business by last-quarter revenue ($148.5M vs $113.1M, roughly 1.3× 1ST SOURCE CORP). 1ST SOURCE CORP runs the higher net margin — 35.3% vs -21.1%, a 56.4% gap on every dollar of revenue. On growth, 1ST SOURCE CORP posted the faster year-over-year revenue change (8.7% vs -19.2%). 1ST SOURCE CORP produced more free cash flow last quarter ($58.1M vs $-28.6M). Over the past eight quarters, 1ST SOURCE CORP's revenue compounded faster (7.8% CAGR vs -7.5%).

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

1st Source Corporation is a financial services company headquartered in South Bend, Indiana. It operates 1st Source Bank, a bank with 81 branches in Indiana and Michigan. The bank's Specialty Finance Group provides financing for aircraft, trucks, and construction equipment. 1st Source Insurance provides insurance products and services.

OPK vs SRCE — Head-to-Head

Bigger by revenue
OPK
OPK
1.3× larger
OPK
$148.5M
$113.1M
SRCE
Growing faster (revenue YoY)
SRCE
SRCE
+27.9% gap
SRCE
8.7%
-19.2%
OPK
Higher net margin
SRCE
SRCE
56.4% more per $
SRCE
35.3%
-21.1%
OPK
More free cash flow
SRCE
SRCE
$86.7M more FCF
SRCE
$58.1M
$-28.6M
OPK
Faster 2-yr revenue CAGR
SRCE
SRCE
Annualised
SRCE
7.8%
-7.5%
OPK

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
OPK
OPK
SRCE
SRCE
Revenue
$148.5M
$113.1M
Net Profit
$-31.3M
$40.0M
Gross Margin
43.1%
Operating Margin
-25.8%
45.4%
Net Margin
-21.1%
35.3%
Revenue YoY
-19.2%
8.7%
Net Profit YoY
-322.8%
6.5%
EPS (diluted)
$-0.04
$1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPK
OPK
SRCE
SRCE
Q1 26
$113.1M
Q4 25
$148.5M
$110.8M
Q3 25
$151.7M
$110.7M
Q2 25
$156.8M
$108.2M
Q1 25
$150.0M
$104.0M
Q4 24
$183.6M
$97.8M
Q3 24
$173.6M
$97.9M
Q2 24
$182.2M
$97.3M
Net Profit
OPK
OPK
SRCE
SRCE
Q1 26
$40.0M
Q4 25
$-31.3M
$41.1M
Q3 25
$21.6M
$42.3M
Q2 25
$-148.4M
$37.3M
Q1 25
$-67.6M
$37.5M
Q4 24
$14.0M
$31.4M
Q3 24
$24.9M
$34.9M
Q2 24
$-10.3M
$36.8M
Gross Margin
OPK
OPK
SRCE
SRCE
Q1 26
Q4 25
43.1%
Q3 25
32.9%
Q2 25
31.5%
Q1 25
28.4%
Q4 24
46.1%
Q3 24
23.1%
Q2 24
28.4%
Operating Margin
OPK
OPK
SRCE
SRCE
Q1 26
45.4%
Q4 25
-25.8%
Q3 25
31.7%
49.7%
Q2 25
-38.3%
44.5%
Q1 25
-44.8%
45.8%
Q4 24
-18.0%
Q3 24
8.2%
46.3%
Q2 24
-33.9%
49.1%
Net Margin
OPK
OPK
SRCE
SRCE
Q1 26
35.3%
Q4 25
-21.1%
37.1%
Q3 25
14.3%
38.2%
Q2 25
-94.7%
34.5%
Q1 25
-45.1%
36.1%
Q4 24
7.6%
32.1%
Q3 24
14.3%
35.7%
Q2 24
-5.7%
37.8%
EPS (diluted)
OPK
OPK
SRCE
SRCE
Q1 26
$1.63
Q4 25
$-0.04
$1.67
Q3 25
$0.03
$1.71
Q2 25
$-0.19
$1.51
Q1 25
$-0.10
$1.52
Q4 24
$0.02
$1.27
Q3 24
$0.03
$1.41
Q2 24
$-0.01
$1.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPK
OPK
SRCE
SRCE
Cash + ST InvestmentsLiquidity on hand
$364.4M
Total DebtLower is stronger
$344.0M
Stockholders' EquityBook value
$1.3B
$1.3B
Total Assets
$1.9B
$9.1B
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPK
OPK
SRCE
SRCE
Q1 26
Q4 25
$364.4M
Q3 25
$412.0M
Q2 25
$267.3M
Q1 25
$428.8M
Q4 24
$426.6M
Q3 24
$400.1M
Q2 24
$40.6M
Total Debt
OPK
OPK
SRCE
SRCE
Q1 26
Q4 25
$344.0M
Q3 25
$344.2M
Q2 25
$343.3M
Q1 25
$439.2M
Q4 24
$437.2M
Q3 24
$441.0M
Q2 24
$201.9M
Stockholders' Equity
OPK
OPK
SRCE
SRCE
Q1 26
$1.3B
Q4 25
$1.3B
$1.3B
Q3 25
$1.3B
$1.2B
Q2 25
$1.3B
$1.2B
Q1 25
$1.3B
$1.2B
Q4 24
$1.4B
$1.1B
Q3 24
$1.4B
$1.1B
Q2 24
$1.4B
$1.0B
Total Assets
OPK
OPK
SRCE
SRCE
Q1 26
$9.1B
Q4 25
$1.9B
$9.1B
Q3 25
$2.0B
$9.1B
Q2 25
$2.0B
$9.1B
Q1 25
$2.1B
$9.0B
Q4 24
$2.2B
$8.9B
Q3 24
$2.3B
$8.8B
Q2 24
$2.0B
$8.9B
Debt / Equity
OPK
OPK
SRCE
SRCE
Q1 26
Q4 25
0.27×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.33×
Q4 24
0.32×
Q3 24
0.31×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPK
OPK
SRCE
SRCE
Operating Cash FlowLast quarter
$-25.9M
$59.1M
Free Cash FlowOCF − Capex
$-28.6M
$58.1M
FCF MarginFCF / Revenue
-19.3%
51.4%
Capex IntensityCapex / Revenue
1.8%
0.9%
Cash ConversionOCF / Net Profit
1.48×
TTM Free Cash FlowTrailing 4 quarters
$-190.8M
$361.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPK
OPK
SRCE
SRCE
Q1 26
$59.1M
Q4 25
$-25.9M
$223.1M
Q3 25
$-34.6M
$51.0M
Q2 25
$-83.4M
$44.9M
Q1 25
$-34.6M
$71.8M
Q4 24
$-44.4M
$193.9M
Q3 24
$-77.1M
$68.4M
Q2 24
$-26.4M
$50.0M
Free Cash Flow
OPK
OPK
SRCE
SRCE
Q1 26
$58.1M
Q4 25
$-28.6M
$213.0M
Q3 25
$-37.8M
$47.3M
Q2 25
$-86.7M
$43.0M
Q1 25
$-37.7M
$69.3M
Q4 24
$-49.8M
$181.5M
Q3 24
$-85.0M
$66.7M
Q2 24
$-33.7M
$46.4M
FCF Margin
OPK
OPK
SRCE
SRCE
Q1 26
51.4%
Q4 25
-19.3%
192.2%
Q3 25
-24.9%
42.7%
Q2 25
-55.3%
39.8%
Q1 25
-25.2%
66.6%
Q4 24
-27.1%
185.5%
Q3 24
-49.0%
68.1%
Q2 24
-18.5%
47.7%
Capex Intensity
OPK
OPK
SRCE
SRCE
Q1 26
0.9%
Q4 25
1.8%
9.1%
Q3 25
2.1%
3.4%
Q2 25
2.1%
1.7%
Q1 25
2.1%
2.4%
Q4 24
2.9%
12.6%
Q3 24
4.6%
1.7%
Q2 24
4.0%
3.7%
Cash Conversion
OPK
OPK
SRCE
SRCE
Q1 26
1.48×
Q4 25
5.42×
Q3 25
-1.60×
1.21×
Q2 25
1.20×
Q1 25
1.91×
Q4 24
-3.17×
6.17×
Q3 24
-3.10×
1.96×
Q2 24
1.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OPK
OPK

Services$71.1M48%
Transfer Of Intellectual Property And Other$33.7M23%
IE$22.1M15%
Rayaldee$8.8M6%
Barda Agreement$6.8M5%
MX$6.3M4%

SRCE
SRCE

Segment breakdown not available.

Related Comparisons